Evaluation of the Prehospital Administration of Tranexamic Acid for Injured Patients: a State-wide Observational Study with Sex and Age-disaggregated Analysis

Overview

Journal Emerg Med J

Specialty Emergency Medicine

Date 2024 Jun 14

PMID 38876768

Authors

Camille Girardello

Pierre-Nicolas Carron

Fabrice Dami

Vincent Darioli

Mathieu Pasquier

Francois-Xavier Ageron

Affiliations

Soon will be listed here.

Abstract

Background: Tranexamic acid (TXA) decreases mortality in injured patients and should be administered as soon as possible. Despite international guidelines recommending TXA in the prehospital setting, its use remains low. The aim of this study was to assess the prehospital administration of TXA for injured patients in a Swiss region.

Methods: We conducted a retrospective observational study in Switzerland between 2018 and 2021. Inclusion criteria were injured patients ≥18 years for whom an ambulance or helicopter was dispatched. The exclusion criterion was minor injury defined by a National Advisory Committee for Aeronautics score <3. The primary outcome was the proportion of patients treated with TXA according to guidelines. The European guidelines were represented by the risk of death from bleeding (calculated retrospectively using the Bleeding Audit for Trauma and Triage (BATT) score). Factors impacting the likelihood of receiving TXA were assessed by multivariate analysis.

Results: Of 13 944 patients included in the study, 2401 (17.2%) were considered at risk of death from bleeding. Among these, 257 (11%) received prehospital TXA. This represented 38% of those meeting US guidelines. For European guidelines, the treatment rate increased with the risk of death from bleeding: 6% (95% CI 4.4% to 7.0%) for low risk (BATT score 3-4); 13% (95% CI 11.1% to 15.9%) for intermediate risk (BATT score 5-7); and 21% (95% CI 17.6% to 25.6%) for high risk (BATT score ≥8) (p<0.01). Women and the elderly were treated less often than men and younger patients, irrespective of the risk of death from bleeding and the mechanism of injury.

Conclusion: The proportion of injured patients receiving TXA in the prehospital setting of the State of Vaud in Switzerland was low, with even lower rates for women and older patients. The reasons for this undertreatment are probably multifactorial and would require specific studies to clarify and correct them.

Citing Articles

A newly developed, easy-to-use prehospital drug-derived score compared with three conventional scores: A prospective multicenter study.

Jurado-Palomo J, Martin-Conty J, Polonio-Lopez B, Bernal-Jimenez J, Conty-Serrano R, Dileone M Eur J Clin Invest. 2024; 55(1):e14329.

PMID: 39373228 PMC: 11628643. DOI: 10.1111/eci.14329.

Urgent action needed on prehospital tranexamic acid in trauma.

Roberts I Emerg Med J. 2024; 41(8):450-451.

PMID: 38876769 PMC: 11287549. DOI: 10.1136/emermed-2024-214194.

References

Bivens M, Fritz C, Burke R, Schoenfeld D, Pope J . State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid. BMC Emerg Med. 2022; 22(1):191. PMC: 9719138. DOI: 10.1186/s12873-022-00741-2. View

Kauvar D, Lefering R, Wade C . Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006; 60(6 Suppl):S3-11. DOI: 10.1097/01.ta.0000199961.02677.19. View

Goodwin L, Nicholson H, Robinson M, Bedson A, Black S, Kirby K . Barriers and facilitators to the administration of prehospital tranexamic acid: a paramedic interview study using the theoretical domains framework. Emerg Med J. 2021; 39(7):540-546. DOI: 10.1136/emermed-2020-210622. View

Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N . The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023; 27(1):80. PMC: 9977110. DOI: 10.1186/s13054-023-04327-7. View

Ageron F, Gayet-Ageron A, Steyerberg E, Bouzat P, Roberts I . Prognostic model for traumatic death due to bleeding: cross-sectional international study. BMJ Open. 2019; 9(5):e026823. PMC: 6549712. DOI: 10.1136/bmjopen-2018-026823. View

Nutbeam T, Roberts I, Weekes L, Shakur-Still H, Brenner A, Ageron F . Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data. Br J Anaesth. 2022; 129(2):191-199. DOI: 10.1016/j.bja.2022.03.032. View

Spahn D, Bouillon B, Cerny V, Coats T, Duranteau J, Fernandez-Mondejar E . Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013; 17(2):R76. PMC: 4056078. DOI: 10.1186/cc12685. View

Heffernan D, Thakkar R, Monaghan S, Ravindran R, Adams Jr C, Kozloff M . Normal presenting vital signs are unreliable in geriatric blunt trauma victims. J Trauma. 2010; 69(4):813-20. DOI: 10.1097/TA.0b013e3181f41af8. View

Haagsma J, Charalampous P, Ariani F, Gallay A, Iburg K, Nena E . The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study. Arch Public Health. 2022; 80(1):142. PMC: 9121595. DOI: 10.1186/s13690-022-00891-6. View

10.

. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019; 394(10210):1713-1723. PMC: 6853170. DOI: 10.1016/S0140-6736(19)32233-0. View

11.

Cole E, Curry N, Davenport R . Sex discrimination after injury: is inequity in tranexamic acid administration just the tip of the iceberg?. Br J Anaesth. 2022; 129(2):144-147. DOI: 10.1016/j.bja.2022.05.015. View

12.

Karl V, Thorn S, Mathes T, Hess S, Maegele M . Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022; 5(3):e220625. PMC: 8889461. DOI: 10.1001/jamanetworkopen.2022.0625. View

13.

Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y . Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32. DOI: 10.1016/S0140-6736(10)60835-5. View

14.

Fischer P, Bulger E, Perina D, Delbridge T, Gestring M, Fallat M . Guidance Document for the Prehospital Use of Tranexamic Acid in Injured Patients. Prehosp Emerg Care. 2016; 20(5):557-9. DOI: 10.3109/10903127.2016.1142628. View

15.

Coats T, Fragoso-Iniguez M, Roberts I . Implementation of tranexamic acid for bleeding trauma patients: a longitudinal and cross-sectional study. Emerg Med J. 2018; 36(2):78-81. DOI: 10.1136/emermed-2018-207693. View

16.

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y . The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377(9771):1096-101, 1101.e1-2. DOI: 10.1016/S0140-6736(11)60278-X. View

17.

Marsden M, Rossetto A, Duffield C, Woolley T, Buxton W, Steynberg S . Prehospital tranexamic acid shortens the interval to administration by half in Major Trauma Networks: a service evaluation. Emerg Med J. 2019; 36(7):395-400. DOI: 10.1136/emermed-2018-208118. View

18.

Roberts I, Edwards P, Prieto D, Joshi M, Mahmood A, Ker K . Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms. Trials. 2017; 18(1):48. PMC: 5282847. DOI: 10.1186/s13063-016-1750-1. View

19.

Chang D, Bass R, Cornwell E, MacKenzie E . Undertriage of elderly trauma patients to state-designated trauma centers. Arch Surg. 2008; 143(8):776-81. DOI: 10.1001/archsurg.143.8.776. View

20.

Gulickx M, Lokerman R, Waalwijk J, Dercksen B, van Wessem K, Tuinema R . Pre-hospital tranexamic acid administration in patients with a severe hemorrhage: an evaluation after the implementation of tranexamic acid administration in the Dutch pre-hospital protocol. Eur J Trauma Emerg Surg. 2023; 50(1):139-147. PMC: 10923991. DOI: 10.1007/s00068-023-02262-4. View